GeneralConnection.com ➔ Dictionary
Dictionary Search

haemophilia b

Synonyms

Noun

1. hemophilia B

2. haemophilia B, Christmas disease, hemophilia, haemophilia, bleeder's disease

Usage
FIX inhibitors pose hurdles for kids with hemophilia B: UK study - Hemophilia News Today
U.S. FDA Approves Pfizer’s HYMPAVZI for the Treatment of Two Additional Hemophilia A or B Patient Populations with Significant Medical Need - Business Wire
Single-Dose Gene Therapy Shows Promising Safety, Efficacy, and Patient-Reported Outcomes in Hemophilia B - Docwire News
PFE Gets FDA Nod for Expanded Use of Hemophilia Drug Hympavzi - Eastern Progress
EAHAD 2026: Nine-Year Outcomes of Gene Therapy - EMJ
Marstacimab in the treatment of patients with hemophilia A and B - Via Medica Journals
Building safeguards for gene therapy in haemophilia - The Lancet
Clinical Scenarios in Hospitalized Patients With Hemophilia - Cureus
Pfizer receives EC approval for Hympavzi to treat haemophilia - Pharmaceutical Technology
CSL Canada Announces First Canadian Patient Receives HEMGENIX® (etranacogene dezaparvovec) Hemophilia B Gene Therapy in Ontario, Canada - Newswire Canada
4 Things to Expect for the Future of Hemophilia Treatment - Docwire News
China’s first hemophilia B gene therapy now approved in Macao - Hemophilia News Today
Hemophilia B Pipeline 2026 Report Highlights Next-Gen Gene Therapies, FDA Advances, and Clinical Momentum Across Novo Nordisk, Pfizer, Sanofi & Emerging Biotechs | DelveInsight - Barchart.com
Distribution of people with hemophilia A in the U.S. in 2024, by age group - Statista
FDA Grants Priority Review For Pfizer’s Marstacimab for Hemophilia A or B - PharmTech.com
The National “New Methods” Decision Forum in Norway recommends CSL’s gene therapy HEMGENIX® for adults with severe or moderately severe haemophilia B without a history of Factor IX inhibitors - Mynewsdesk
European Commission Approves Pfizer’s HYMPAVZI for the Treatment of Adults and Adolescents with Hemophilia A or B With Inhibitors - Business Wire
(marstacimab) sBLA for the Treatment of Two Hemophilia A or B Patient Populations with Significant Medical Need - Business Wire
New gene therapy reduces bleeding rates for hemophilia B patients - Hemophilia News Today
Hull teenager first to be treated with new haemophilia drug - BBC
Haemophilia A vs B: Which is more severe? Here’s what sets them apart - TheHealthSite
How durable is gene therapy for haemophilia B? - Nature
How pioneering gene therapy changed the life of the first man in Wales to receive it - Nation.Cymru
Final Analysis of a Study of Etranacogene Dezaparvovec for Hemophilia B - The New England Journal of Medicine
Factor IX-Padua AAV gene therapy in hemophilia B: phases 1/2 and 3 trials - Nature
Explainer: Why Is Hemophilia B Called Christmas Disease? - Global Biotechnology Company
Optimization of hemophilia B treatment via population PK modeling of rIX-FP, including a 3-week regimen - Frontiers
Marstacimab Superior to On-Demand Prophylaxis for Hemophilia A, B, With Inhibitors - Docwire News
Gene therapy can help reduce joint bleeds in hemophilia B: New data - Hemophilia News Today
‘A game-changer for our son’: City teen first in UK to be treated with new haemophilia drug - The Hull Story
Pfizer says patient dies after receiving hemophilia drug in trial - ETPharma.com
Gene Therapy with Etranacogene Dezaparvovec for Hemophilia B - The New England Journal of Medicine
First patient in Wales receives ground-breaking gene therapy treatment - Nation.Cymru
World Haemophilia Day: Over 5,000 Kenyans living with blood disorder - KBC Digital
Groundbreaking treatment for haemophilia administered in Wales for first time - Nation.Cymru
Haemophilia injections hailed as ‘real step forward’ for sufferers - STV News
First subject dosed in Be Biopharma’s trial of haemophilia B therapy - Clinical Trials Arena
From Bleeds To Prevention, India’s Haemophilia Care Is At A Turning Point | World Haemophilia Day Special - ETV Bharat
Hemophilia B gene therapy demonstrates long-term success - St. Jude Children's Research Hospital
ASH: CSL proves efficacy of hemophilia B gene therapy Hemgenix holds up after 5 years - Fierce Pharma
Sustained Clinical Benefit of AAV Gene Therapy in Severe Hemophilia B - The New England Journal of Medicine
First gene therapy to treat haemophilia B - European Medicines Agency (EMA)
Exploring Eptacog Beta Dosing in Patients With Hemophilia A or B - Docwire News
Phase 3 Analysis: Concizumab Noninferior to Prior Prophylaxis in Hemophilia A, B, Without Inhibitors - Docwire News
CDC Hemophilia Mutation Projects (CHAMP and CHBMP) - Centers for Disease Control and Prevention | CDC (.gov)
Phase 1–2 Trial of AAVS3 Gene Therapy in Patients with Hemophilia B - The New England Journal of Medicine
Gene therapy comes of age to staunch hemophilia B - St. Jude Children's Research Hospital
Patients With Hemophilia Face Significant Burden Despite Treatment Type or Disease Severity - Docwire News
Non-replacement therapy for people with haemophilia B: another step towards health equity - The Lancet
AAV Gene Therapy in Severe Hemophilia B - The New England Journal of Medicine
With hemophilia B, a lifetime of worry eased with one infusion - Penn Today
Tailored collagen binding of albumin-fused hyperactive coagulation factor IX dictates in vivo distribution and functional properties - Nature
Steven W. Pipe, MD, on the End-of-Study Results From Hemgenix’s HOPE-B Trial - CGTLive®
First-in-human trial of hemophilia B treatment BE-101 starts dosing - Hemophilia News Today
Pfizer’s Hympavzi significantly reduces bleeds in haemophilia patients - PMLiVE
AAV gene therapy shows durable benefit in hemophilia B - 2 Minute Medicine
AI-Driven Applications Changing the Management of Hemophilia - Hematology Advisor
Transformational therapy cures haemophilia B - BBC
Gene Therapy with Fidanacogene Elaparvovec in Adults with Hemophilia B - The New England Journal of Medicine
Therapeutic efficacy in a hemophilia B model using a biosynthetic mRNA liver depot system - Nature
NMPA approves BBM and Takeda China’s haemophilia B therapy - Pharmaceutical Technology
First German haemophilia B patient receives gene therapy HEMGENIX - PharmaTimes
Hemophilia B Gene Therapy Shows Promise as Long-Term Treatment - Docwire News
Eloctate, Alprolix control bleeds in hemophilia patients’ major surgeries - Hemophilia News Today
Hemophilia B gene therapy benefits last more than a decade: Study - Hemophilia News Today
CSL Behring treats two patients with gene therapy for haemophilia B - Clinical Trials Arena
CRISPR/Cas9-mediated genome editing via postnatal administration of AAV vector cures haemophilia B mice - Nature
China Explores Weight-Based Pricing for First Domestic Hemophilia B Gene Therapy - NAVLIN DAILY
Phase 3 Trial of Concizumab in Hemophilia with Inhibitors - The New England Journal of Medicine
Nonfactor Therapies for Hemophilia: Current Evidence, Clinical Relevance and Cost Considerations - Managed Healthcare Executive
Single-dose gene therapy is potentially life-changing for adults with hemophilia B - Penn Medicine
FDA approves Alhemo® as once-daily prophylactic treatment to prevent or reduce the frequency of bleeding episodes for adults and children 12 years of age and older with hemophilia A or B (HA/HB) without inhibitors - PR Newswire
Real Stories from People Living with Hemophilia - Centers for Disease Control and Prevention | CDC (.gov)
CSL doses first patient with haemophilia B gene therapy Hemgenix - Pharmaceutical Technology
Spotlight on the ISTH Hemophilia Treatment Guidelines and Alternate Recommendations - Hematology Advisor
Breaking ground in haemophilia B gene therapy: insights from the HOPE-B trial and beyond - The Lancet
Haemophilia gene therapy patients thriving over a decade after treatment - UCL | University College London
Freeline Therapeutics doses first subject in haemophilia B therapy trial - Clinical Trials Arena
Long-Term Safety and Efficacy of Factor IX Gene Therapy in Hemophilia B - The New England Journal of Medicine
UK Approves Marstacimab for Severe Haemophilia A or B - Medscape
Novo Nordisk’s Alhemo approved by FDA for expanded haemophilia use - PMLiVE
How to Plan for Emergencies When You Have Hemophilia B - Everyday Health
FDA approves first gene therapy for hemophilia B - BioPharma Dive
$3.5-Million Hemophilia Gene Therapy Is World’s Most Expensive Drug - Scientific American
Hemophilia gene therapy: A new era of treatment and the obstacles ahead - Drug Discovery News
NICE recommends weekly injection for severe haemophilia B - The Pharmaceutical Journal
Pfizer’s hemophilia B gene therapy inches closer to regulatory approval - BioPharma Dive
uniQure announces FDA approval of first gene therapy for adults with hemophilia B - uniqure.gcs-web.com
Gene therapy BBM-H901 approved for hemophilia B in China - Hemophilia News Today
Phase 1/2 clinical trial of BE-101 now enrolling hemophilia B patients - Hemophilia News Today
Etranacogene Dezaparvovec Gene Therapy Outperforms FIX Products in Hemophilia B - AJMC
Characteristics of FXa-storing platelets in hemophilia B mice and the influence of alcohol on the platelets - Nature
Intellia ending work with Regeneron on gene therapy for hemophilia B - Hemophilia News Today
A 'transformative' gene therapy for haemophilia B - The Week
After 4 years, hemophilia B bleeding rates remain low with Hemgenix - Hemophilia News Today
In about-face, hemophilia B therapy Hemgenix to be covered by NHS - Hemophilia News Today
Hemophilia B Market Size to Reach USD 24.7 Billion by 2035, Impelled by Advancements in Gene Therapy - BioSpace
CRISPR/Cas9 for hemophilia - Hemophilia News Today
Case Closed: Famous Royals Suffered From Hemophilia - Science | AAAS
Safety and activity of an engineered, liver-tropic adeno-associated virus vector expressing a hyperactive Padua factor IX administered with prophylactic glucocorticoids in patients with haemophilia B: a single-centre, single-arm, phase 1, pilot trial - The Lancet
Foreign Language Equivalents
Foreign Language Equivalents of 'haemophilia b'
Language Equivalent   Language Equivalent
French    Spanish
Misspellings - Typos
haemmophilia b,   haemophiliab,   haemophlia b,   haeophilia b,   haemophilia b,   haempphilia b,   haemophiilia b,   hameophilia b,   hhaemophilia b,   haemiphilia b,   haemopjilia b,   haemopgilia b,   haenophilia b,   hemophilia b,   haemopholia b,   haemophilis b,   ahemophilia b,   haemophiliab ,   aemophilia b,   haemohpilia b,   haemophi;ia b,   gaemophilia b,   haemophulia b,   hawmophilia b,   haemoohilia b,   haemophillia b,   haemophiliia b,   haemophilai b,   haemophiia b,   haemohilia b,   haemophilia n,   haemophilia bb,   haemopihlia b,   heamophilia b,   haemo[hilia b,   haempohilia b,   haemophliia b,   haemophilia ,   haemophili ab,   haemphilia b,   haemoophilia b,   hae,ophilia b,   haemophiliaa b,   haemopilia b,   haeemophilia b,   hsemophilia b,   haemophikia b,   haemophilia v,   haemophilua b,   haemophila b,   haemophhilia b,   haemophiloa b,   haaemophilia b,   jaemophilia b,   harmophilia b,   haemophili b,   haeomphilia b,   haemophiila b,   hamophilia b,   haemopphilia b
Words Starting with Letter - 'A'
a a battery a billion
a bit a bit much a capella singing
a cappella singing a couple of a few
a fortiori a good deal a great deal
a horizon a hundred a hundred and one
a hundred thousand a hundred times a kempis
a la carte a la mode a level
a little a lot a million
Go to Page 1              Go to Page 2 »   
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z